The Journal of Immunology, Vol 150, Issue 1 265-277, Copyright © 1993 by American Association of Immunologists

ARTICLES

Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft- versus-host disease induced across the major histocompatibility barrier

BR Blazar, PA Taylor, DC Snover, JA Bluestone and DA Vallera
Department of Pediatrics, University of Minnesota Hospital and Clinic, Minneapolis 55455.

We have investigated the in vivo administration of nonmitogenic anti- CD3F(ab')2 fragments for the prevention of lethal graft-vs-host disease (GVHD) in irradiated recipients of fully allogeneic bone marrow cells plus splenocyte (BMS) inocula. Recipients of anti-CD3F(ab')2 fragments administered for 1 mo post-bone marrow transplantation (BMT) had 100% survival without clinical or histopathological evidence of GVHD. Controls given saline injections succumbed by 39 days post-BMT. Similar results were obtained in groups of recipient mice given BMS in which T cells were depleted by in vitro anti-Thy-1.2 plus C' treatment. Further studies were undertaken to define mechanistic differences in the two approaches. Using Ly-5 congenic sources of donor bone marrow and spleen, we determined that anti-CD3F(ab')2 fragments induced TCR modulation and T cell depletion. Mature splenic-derived CD4+ cells were depleted to a greater extent than CD8+ cells. Early post-BMT, recipients receiving injections with control saline had the highest number of CD4+ and CD8+ cells (which may cause GVHD) followed by recipients of anti-CD3F(ab')2 fragments, with the fewest CD8+ cells observed in the anti-Thy-1.2 + C' treated group. CD3+CD4-CD8- cells (which may suppress GVHD generation) were present in higher numbers early post-BMT in recipients given anti-CD3F(ab')2 fragments as compared to recipients given anti-Thy-1.2 + C'-treated BMS. In long term survivors, a mononuclear T cell containing infiltrate without evidence of destruction was observed in sites of GVHD (lung and liver), consistent with a "Quilty" effect, which was not observed in either of the other two groups. Although survivors were tolerant of donor skin grafts and rejected third party grafts, recipients given anti- CD3F(ab')2 fragments but not anti-Thy-1.2 + C'-treated BMS had vigorous anti-host proliferative responses. These results demonstrate that although in vitro anti-Thy-1.2 + C' treatment of BMS (which is highly depletionary) and in vivo administration of anti-CD3F(ab')2 fragments (which is modulatory and less depletionary) are both effective strategies for GVHD, the cellular events involved in achieving GVHD prevention are indeed different.

This article has been cited by other articles:

				J. Smith, P.-C. Lai, J. Behmoaras, C. Roufosse, G. Bhangal, J. P McDaid, T. Aitman, F. W. Tam, C. D. Pusey, and H. T. Cook Genes Expressed by Both Mesangial Cells and Bone Marrow-Derived Cells Underlie Genetic Susceptibility to Crescentic Glomerulonephritis in the Rat J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1816 - 1823. [Abstract] [Full Text] [PDF]

				A. Panoskaltsis-Mortari, R. M. Strieter, J. R. Hermanson, K. V. Fegeding, W. J. Murphy, C. L. Farrell, D. L. Lacey, and B. R. Blazar Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation Blood, August 1, 2000; 96(3): 834 - 839. [Abstract] [Full Text] [PDF]

				D. A. Vallera, D. W. Kuroki, A. Panoskaltsis-Mortari, D. J. Buchsbaum, B. E. Rogers, and B. R. Blazar Molecular modification of a recombinant anti-CD3epsilon -directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model Blood, August 1, 2000; 96(3): 1157 - 1165. [Abstract] [Full Text] [PDF]

				A. Panoskaltsis-Mortari, D. H. Ingbar, P. Jung, I. Y. Haddad, P. B. Bitterman, O. D. Wangensteen, C. L. Farrell, D. L. Lacey, and B. R. Blazar KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L988 - L999. [Abstract] [Full Text] [PDF]

				E. K. Waller, A. M. Ship, S. Mittelstaedt, T. W. Murray, R. Carter, I. Kakhniashvili, S. Lonial, J. T. Holden, and M. W. Boyer Irradiated Donor Leukocytes Promote Engraftment of Allogeneic Bone Marrow in Major Histocompatibility Complex Mismatched Recipients Without Causing Graft-Versus-Host Disease Blood, November 1, 1999; 94(9): 3222 - 3233. [Abstract] [Full Text] [PDF]

				I. Y. Haddad, A. Panoskaltsis-Mortari, D. H. Ingbar, S. Yang, C. E. Milla, and B. R. Blazar High Levels of Peroxynitrite Are Generated in the Lungs of Irradiated Mice Given Cyclophosphamide and Allogeneic T Cells . A Potential Mechanism of Injury after Marrow Transplantation Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1125 - 1135. [Abstract] [Full Text]

				A. Panoskaltsis-Mortari, D. L. Lacey, D. A. Vallera, and B. R. Blazar Keratinocyte Growth Factor Administered Before Conditioning Ameliorates Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice Blood, November 15, 1998; 92(10): 3960 - 3967. [Abstract] [Full Text] [PDF]